-
Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression
Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P.-P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J. & Michels, M., 15 Oct 2025, In: International Journal of Cardiology. 437, 133444.Research output: Contribution to journal › Article › Academic › peer-review
-
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial
van Driel, B. O., Schoonvelde, S. A. C., Borodzicz-Jazdzyk, S., Huurman, R., Visch, J., Robbers, L., Harms, H., Verhagen, J., Vermeer, A., van den Aardweg, J., van Rossum, A. C., Germans, T., Michels, M. & van der Velden, J., 1 Oct 2025, In: Cardiovascular Research. 121, 12, p. 1917-1928Research output: Contribution to journal › Article › Academic › peer-review
-
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)–Positive Individuals
van der Heide, M. Y. C., Verstraelen, T. E., de Brouwer, R., van Drie, E., Proost, V. M., van Lint, F. H. M., Bosman, L. P., Houweling, A. C., Dickhoff, C., Germans, T., Schoonderwoerd, B. A., Gimeno-Blanes, J. R., Meems, L. M. G., te Riele, A. S. J. M., van Spaendonck-Zwarts, K. Y., Cox, M. G. P. J., Amin, A. S., van Tintelen, J. P., de Boer, R. A. & Zwinderman, A. H. & 1 others, , 1 Oct 2025, In: JACC: Heart Failure. 13, 10, 102558.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
